Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Novartis Sees Real Value Of Ofatumumab In MS, Pays GSK Up To $1Bn

Aug 21 2015

• By Sukaina Virji

Related Companies

Teva Pharmaceutical Industries Ltd.

Novartis AG

Genmab A/S

Additional Topics

Companies Deals Dermatology Neurology

More from Dermatological

More from Therapeutic Category

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.